MedTrace Logo

CSP vs EMR for >6mm Superficial Non-ampullary Duodenal Tumors

NCT05428553 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 183

Last updated 2022-06-23

No results posted yet for this study

Summary

There is currently no reliable evidence on the safety of CSP (cold snare polypectomy) / p-CSP (piecemeal CSP) for SNADT greater than 6mm.In this prospective historical controlled study, we intend to test the role of CSP / p-CSP in the treatment of pedicle less snadt greater than 6mm compared with EMR (endoscopic mucosal resection) / EPMR (endoscopic piecemeal mucosal resection).

Conditions

  • Duodenal Tumor

Interventions

PROCEDURE

Endoscopic resection: CSP/p-CSP

Patients in the experimental arm will be assigned to receive CSP/p-CSP.

PROCEDURE

Endoscopic resection: EMR/EPMR

Patients in the historical control arm have already finished EMR/EPMR

Sponsors & Collaborators

  • Shanghai Zhongshan Hospital

    lead OTHER

Principal Investigators

  • Ping-Hong Zhou, MD,PhD · Shanghai Zhongshan Hospital

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-06-01
Primary Completion
2023-03-31
Completion
2023-11-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05428553 on ClinicalTrials.gov